JP2024506375A5 - - Google Patents
Info
- Publication number
- JP2024506375A5 JP2024506375A5 JP2023548848A JP2023548848A JP2024506375A5 JP 2024506375 A5 JP2024506375 A5 JP 2024506375A5 JP 2023548848 A JP2023548848 A JP 2023548848A JP 2023548848 A JP2023548848 A JP 2023548848A JP 2024506375 A5 JP2024506375 A5 JP 2024506375A5
- Authority
- JP
- Japan
- Prior art keywords
- dna
- composition according
- domain
- modification
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163149419P | 2021-02-15 | 2021-02-15 | |
| US63/149,419 | 2021-02-15 | ||
| PCT/US2022/016313 WO2022174144A1 (en) | 2021-02-15 | 2022-02-14 | Site-specific genome modification technology |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506375A JP2024506375A (ja) | 2024-02-13 |
| JP2024506375A5 true JP2024506375A5 (https=) | 2025-02-20 |
Family
ID=82837338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023548848A Pending JP2024506375A (ja) | 2021-02-15 | 2022-02-14 | 部位特異的ゲノム修飾技術 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240229012A9 (https=) |
| EP (1) | EP4291664A4 (https=) |
| JP (1) | JP2024506375A (https=) |
| CN (1) | CN117222741A (https=) |
| WO (1) | WO2022174144A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118620868A (zh) * | 2023-03-07 | 2024-09-10 | 上海科技大学 | IscBn-ωRNA编辑系统及其应用 |
| AU2024236558A1 (en) | 2023-03-15 | 2025-10-09 | Renagade Therapeutics Management Inc. | Delivery of gene editing systems and methods of use thereof |
| AU2024335327A1 (en) | 2023-09-01 | 2026-03-26 | Renagade Therapeutics Management Inc. | Gene editing systems, compositions, and methods for treatment of vexas syndrome |
| WO2025064917A1 (en) * | 2023-09-21 | 2025-03-27 | North Carolina State University | Programmable base editing |
| WO2025174765A1 (en) | 2024-02-12 | 2025-08-21 | Renagade Therapeutics Management Inc. | Lipid nanoparticles comprising coding rna molecules for use in gene editing and as vaccines and therapeutic agents |
| CN121495966B (zh) * | 2026-01-13 | 2026-04-17 | 山东大学 | 一种高效无痕编辑黏细菌基因组的方法及应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015021426A1 (en) | 2013-08-09 | 2015-02-12 | Sage Labs, Inc. | A crispr/cas system-based novel fusion protein and its application in genome editing |
| US20150165054A1 (en) * | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting caspase-9 point mutations |
| WO2017040511A1 (en) * | 2015-08-31 | 2017-03-09 | Agilent Technologies, Inc. | Compounds and methods for crispr/cas-based genome editing by homologous recombination |
| WO2018152197A1 (en) * | 2017-02-15 | 2018-08-23 | Massachusetts Institute Of Technology | Dna writers, molecular recorders and uses thereof |
| US20220098619A1 (en) * | 2018-12-10 | 2022-03-31 | The Board Of Trustees Of The Leland Stanford Junior University | Anti-crispr-mediated control of genome editing and synthetic circuits in eukaryotic cells |
-
2022
- 2022-02-14 JP JP2023548848A patent/JP2024506375A/ja active Pending
- 2022-02-14 EP EP22753488.0A patent/EP4291664A4/en active Pending
- 2022-02-14 WO PCT/US2022/016313 patent/WO2022174144A1/en not_active Ceased
- 2022-02-14 CN CN202280027473.3A patent/CN117222741A/zh active Pending
- 2022-02-14 US US18/546,378 patent/US20240229012A9/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024506375A5 (https=) | ||
| US20240392303A1 (en) | RNA TARGETING OF MUTATIONS VIA SUPPRESSOR tRNAs AND DEAMINASES | |
| JP7698828B2 (ja) | Ｒｎａを編集する方法および組成物 | |
| CN113631708B (zh) | 编辑rna的方法和组合物 | |
| US20250084397A1 (en) | Methods of purifying dna for gene synthesis | |
| US20240425902A1 (en) | Methods of purifying dna for gene synthesis | |
| AU2020346880B2 (en) | Modified bacterial retroelement with enhanced DNA production | |
| Pelczar et al. | The host gene for intronic U17 small nucleolar RNAs in mammals has no protein-coding potential and is a member of the 5′-terminal oligopyrimidine gene family | |
| JP2021118714A (ja) | Ｃｒｉｓｐｒ系組成物及び使用方法 | |
| CN113994000A (zh) | 包括胞苷类似物的反义rna编辑寡核苷酸 | |
| EP3682004A2 (en) | Multiplex production and barcoding of genetically engineered cells | |
| JP2018522249A (ja) | Ｃａｓ９分子／ガイドｒｎａ分子複合体の評価 | |
| JP7078946B2 (ja) | ゲノム編集方法 | |
| US20250146005A1 (en) | Methods of making circular rna | |
| EP4534675A1 (en) | Method for site-specific insertion of exogenous sequence in genome | |
| WO2023206871A1 (zh) | 一种优化的CRISPR/SpCas12f1系统、工程化向导RNA及其应用 | |
| WO2023206872A1 (zh) | 一种工程优化的核酸酶、向导rna、编辑系统和应用 | |
| GB2615901A (en) | Base editing enzymes | |
| CN105602972B (zh) | 基于CRISPR-Cas9体外改造腺病毒载体的方法 | |
| WO2025045078A1 (zh) | 一种用于调控rna甲基化修饰的编辑系统及其应用 | |
| JP7133856B2 (ja) | 細胞内在性のｄｎａ修飾酵素を利用して標的化したｄｎａの核酸塩基を特異的に変換する、細胞の核酸配列の変換方法、及びそれに用いる分子複合体 | |
| Sjakste et al. | Tightly bound to DNA proteins: possible universal substrates for intranuclear processes | |
| EP4578946A1 (en) | Optimized guide rna, crispr/acc2c9 gene editing system, and gene editing method | |
| CN115725650B (zh) | 实现a到c和/或a到t碱基突变的碱基编辑系统及其应用 | |
| CN120004994A (zh) | 一种胞嘧啶脱氨酶抑制剂SflSddi及其应用 |